HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reply to: Comments on: Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein.

AuthorsRouslan Kotchetkov, David Susman, Divaya Bhutani, Kaspar Broch, Angela Dispenzieri, Francis K Buadi
JournalInternational journal of cancer (Int J Cancer) Vol. 149 Issue 3 Pg. 743-744 (08 01 2021) ISSN: 1097-0215 [Electronic] United States
PMID33742687 (Publication Type: Letter, Comment)
Chemical References
  • Antibodies, Monoclonal
Topics
  • Antibodies, Monoclonal
  • Humans
  • Myopathies, Nemaline (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: